SLNO
Soleno Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$53.01
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+34.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Mar 31, 2026 | Manning Meredith · officer: Chief Commercial Officer | Sale | 2,100 | $31 |
| Mar 31, 2026 | Manning Meredith · officer: Chief Commercial Officer | Sale | 558 | $32 |
| Mar 31, 2026 | Huang Michael F. · officer: Sr. VP of Clinical Development | Sale | 488 | $32 |
| Mar 31, 2026 | Manning Meredith · officer: Chief Commercial Officer | Sale | 4,864 | $30 |
| Mar 31, 2026 | Huang Michael F. · officer: Sr. VP of Clinical Development | Sale | 1,838 | $31 |
| Mar 31, 2026 | Huang Michael F. · officer: Sr. VP of Clinical Development | Sale | 4,256 | $30 |
| Mar 4, 2026 | Fulk Jennifer · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 67,660 | $39 |
| Mar 4, 2026 | Fulk Jennifer · officer: CHIEF FINANCIAL OFFICER | A-Award | 39,200 | $0.00 |
| Jan 23, 2026 | Anish Bhatnagar · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 114,200 | $0.00 |
| Jan 23, 2026 | Yen Kristen · officer: SEE REMARKS | A-Award | 11,900 | $44 |
| Jan 23, 2026 | Huang Michael F. · officer: Sr. VP of Clinical Development | A-Award | 11,900 | $44 |
| Jan 23, 2026 | Joshi Manher · officer: Chief Development Officer | A-Award | 4,100 | $0.00 |
| Jan 23, 2026 | Norrett Kevin · officer: Chief Business Officer | A-Award | 4,000 | $44 |
| Jan 23, 2026 | Yen Kristen · officer: SEE REMARKS | A-Award | 10,400 | $0.00 |
| Jan 23, 2026 | Joshi Manher · officer: Chief Development Officer | A-Award | 4,700 | $44 |
| Jan 23, 2026 | Huang Michael F. · officer: Sr. VP of Clinical Development | A-Award | 10,400 | $0.00 |
| Jan 23, 2026 | Anish Bhatnagar · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 131,400 | $44 |
| Jan 23, 2026 | Hirano Patricia C · officer: SEE REMARKS | A-Award | 11,900 | $44 |
| Jan 23, 2026 | Mackaness James H · officer: CHIEF FINANCIAL OFFICER | A-Award | 32,800 | $44 |
| Jan 23, 2026 | Mackaness James H · officer: CHIEF FINANCIAL OFFICER | A-Award | 28,600 | $0.00 |
| Jan 23, 2026 | Manning Meredith · officer: Chief Commercial Officer | A-Award | 32,800 | $44 |
| Jan 23, 2026 | Hirano Patricia C · officer: SEE REMARKS | A-Award | 10,400 | $0.00 |
| Jan 23, 2026 | Norrett Kevin · officer: Chief Business Officer | A-Award | 3,500 | $0.00 |
| Jan 23, 2026 | Manning Meredith · officer: Chief Commercial Officer | A-Award | 28,600 | $0.00 |
| Dec 17, 2025 | Huang Michael F. · officer: Sr. VP of Clinical Development | F-InKind | 812 | $50 |
| Dec 17, 2025 | Anish Bhatnagar · director, officer: CHIEF EXECUTIVE OFFICER | F-InKind | 7,620 | $50 |
| Dec 17, 2025 | Manning Meredith · officer: Chief Commercial Officer | F-InKind | 1,922 | $50 |
| Dec 17, 2025 | Hirano Patricia C · officer: SEE REMARKS | F-InKind | 904 | $50 |
| Dec 17, 2025 | Mackaness James H · officer: CHIEF FINANCIAL OFFICER | F-InKind | 2,013 | $50 |
| Dec 17, 2025 | Yen Kristen · officer: SEE REMARKS | F-InKind | 904 | $50 |
Institutional positioning
13F filings over the trailing two quarters
New 44Increased 91Reduced 75Sold out 227
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | Reduced | 7,099,328 | May 18, 2026 |
| FMR LLC | Reduced | 5,788,410 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 4,426,781 | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 3,742,774 | May 13, 2026 |
| AVORO CAPITAL ADVISORS LLC | Increased | 2,900,000 | Mar 16, 2026 |
| STATE STREET CORP | Increased | 2,680,802 | May 15, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | Increased | 2,494,124 | May 15, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 2,300,000 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,153,218 | May 15, 2026 |
| POLAR CAPITAL HOLDINGS PLC | Increased | 1,698,855 | May 15, 2026 |
| CAPTION MANAGEMENT, LLC | Increased | 1,589,343 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 1,567,977 | May 15, 2026 |
| KHROM CAPITAL MANAGEMENT LLC | New Position | 1,511,481 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1,237,550 | May 15, 2026 |
| WOODLINE PARTNERS LP | Increased | 1,112,104 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Mar 31, 2026